Neuralink Research & Development – Dr. John Doe

Neuralink Research & Development Big text

Date: April 3rd, 2035

Name: Dr. John Doe

Position: Head of R&D Department

Location: Neuralink Research Facility, California, United States

Today was the day we have been waiting for. We had been told last week that we must change our materials to become more readily available, as we have started ramping up production of the Neuralink chip for medical uses.

This morning, shipments for the new material were approved, and we will be receiving them as soon as by the start of the new week. As great as this is, we are now forced to recreate our motherboard in the chip using a lower quality source of gold, and this will result in more electrical interference and an increase in temperature on the processing units. We have theorized that by mixing copper and gold together, we can create a compound that is both conductive electricity and conducive to heat absorption.

Our new resources are sourced from Canada, specifically northern Ontario. The area is rich in minerals such as gold and lithium, both of which we actively use in our chip production. As of now, sustainability is projected to last until early 2050s, however some projections show that as early as the 2040s production can falter, causing us to need to source or cut back on production.

In terms of current goals and expectations of the chip, we are seeing steady progress in the restoration of motor function in hospitalized veterans who have received the chip in the last year. Reports back from Toronto General Hospital report that some form of motor function has returned to paralyzed veterans. Patients can wiggle their toes, whereas years before they were unable to move any extremities at all. Our chip seems to be interfacing with their nerves well, also returning feeling to the affected areas.

In even more hopeful news, patients with robotic features have reported increased cases of dexterity, resulting in more precise control of joints, especially finger joints. When interviewed, patients reported that their mental health and quality of live has improved drastically since the installation of our chip.

Thought to speech implementation is going well. Users have reported being able to send and receive text messages to one other entirely done by Neuralink. This will be beneficial for users who cannot speak, as well as those who are not comfortable expressing themselves. As of now, thought to speech is not able, a we cannot yet allow the Neuralink to connect the correct nerves in the brain to stimulate speech.

Our users with neurological disorders, specifically memory related ones such as Alzheimer’s are reporting an increased in cognitive function and ability to remain lucid for longer periods of time. There have been improvements in long-term memory of users, with users recalling details and storing said details in their accessible memory in the chip. Although users cannot repeatably recall memories, they are accessing onboard memories saved in the chip easily, providing another medium for them to retain these memories. More studies need to take place; however, the preliminary data seem positive, and with an increase in users we expect data sets to increase.

Brain mapping of users with mood regulation disorders has been improving. Just this month, we were able to reliably recreate scans of users’ brains affected by depression, pinpointing specific areas where synapse is most active during said episodes. We are testing methods to provide short low energy electrical pulses to affected areas, with the hope of stimulating these areas to cause intended effects in the users. As of now, we are aiming for this interface to be available only upon recommendation by Neuralink trained doctors and installation from our main facility in California. However, we believe this can prove to be a less invasive way to treat mental health disorders, ideally eliminating the common side effects of mood regulation drugs. Additionally, we have been able to quickly anticipate users who began suffering from seizures, and we were able to diagnose the affliction right away when already in hospital, being able to administer aid as soon as possible. We used this data to ideally treat efficiently, and we have passed this onto participating medical facilities.

We are expected to roll out user to user communication methods soon, however we are currently having difficulty creating the interface in which this will take place. We have made strides in the implementation of knowledge transference however, and users can send each other data and information saved on their memory chips freely. We expect this update to be sent out in the coming months when more users complete their installation progress.

As of now, we are having trouble maintaining secure roots for procurement of materials used for manufacturing. However, the new deal mentioned above should ideally allow us to continue with the large increase of demand in recent years.

Additionally, societal pressure on “elites” in society getting the implant has caused a massive increase in demand for our product. Due to this, we have been getting complaints daily to our customer service department, claiming we are causing a divide to form in large metropolitan areas. While we cannot deny that there is a divide forming, we cannot change our course, as we can ideally make Neuralink affordable for all.

We will continue to push updates to innovate our chip, ideally reaffirming the safety of our users.